3279 |
Korea Sapien 3 Case Experience |
Kiyuk Chang |
Apr. 25. 17 |
3278 |
Building Evidence for Treating Lower Risk Patients: Recent Updates From Evolut R Technology and Evidence |
Eberhard Grube |
Apr. 25. 17 |
3277 |
Irregular Protrusion: Impact of Stent Platform |
Yutaka Hikichi |
Apr. 25. 17 |
3276 |
Introducing CoreWire Technology & Challenging Case with Onyx |
Ho Lam |
Apr. 25. 17 |
3275 |
Clinical Practice of BioFreedom¢â and Short Duration DAPT for High Bleeding Risk Patients |
Byeong-Keuk Kim |
Apr. 25. 17 |
3274 |
Who Is Going to Bleed? |
Gaku Nakazawa |
Apr. 25. 17 |
3273 |
LEADERS Free Two Years Follow-up |
Fahim Haider Jafary |
Apr. 25. 17 |
3272 |
Future Clinical Role of IMR or Microcirculation Study |
Bon-Kwon Koo |
Apr. 25. 17 |
3271 |
Issues about Drift with FFR, cFFR, and iFR: How to Avoid It, How to Live with It, and Practical Tips |
Nico Pijls |
Apr. 25. 17 |
3270 |
DEFINE FLAIR: iFR vs. FFR Guided PCI |
Justin E. Davies |
Apr. 25. 17 |